Clinical Trials Browser

Phase NA × Recruiting × Leukemia, Myeloid × Clear all

NCT06643962 2024-11-12

Venetoclax Combined with Intensive Therapy for Acute Myeloid Leukemia Patients with Lower Early Peripheral Blast Clearance Rate After Standard Induction Therapy

Phase NA Recruiting

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute